放射学阳性中轴型脊柱关节炎患者接受TNF-α抑制剂治疗8年期间骨密度改善与新发椎体骨折
在GLAS前瞻性队列中,126例接受TNFi至少8年的r-axSpA患者(排除抗骨质疏松治疗者)每两年测量腰椎骨密度(DEXA)并以Genant分级评估脊柱X线椎体骨折。腰椎骨密度Z评分在4年内显著改善并维持,但90例有基线及8年影像者中14例(16%)出现新发椎体骨折、5例(6%)原有骨折加重。
要点
- 腰椎骨密度Z评分在治疗前4年显著改善,中位较基线改善8.9%(2.8-15.8),8年时为7.2%(2.2-14.7)。
- 90例有基线与8年影像的患者中,14例(16%)出现新发椎体骨折,5例(6%)原有骨折严重度增加。
- 8年时44处椎体骨折中30%为2级(n=12)或3级(n=1)。
核心结论
- 在r-axSpA患者接受TNFi治疗8年期间,腰椎骨密度Z评分显著升高,尤其在前4年。
- 尽管骨密度改善,放射学椎体骨折仍继续新发或进展。
研究设计与样本
- 来自GLAS前瞻性队列的连续axSpA患者,接受TNFi至少8年,排除接受抗骨质疏松治疗者。
- 共纳入126例axSpA患者;75%为男性,平均年龄42±11岁,ASDAS 3.8±0.8,腰椎骨密度Z评分中位-0.5(IQR -1.4-0.7),20%基线有放射学椎体骨折。
- 腰椎骨密度在基线、1年及之后每两年以DEXA评估,放射学椎体骨折采用Genant分级评估。
主要发现
- 疾病活动度快速改善并持续。
- 腰椎骨密度Z评分较前一时间点显著改善至4年,此后维持。
- 较基线改善的中位百分比在4年和8年时分别为8.9%(2.8-15.8)和7.2%(2.2-14.7)。
- 90例有基线与8年影像的患者中,14例(16%)出现新发椎体骨折,5例(6%)原有椎体骨折严重度增加。
- 8年时全部44处椎体骨折中,30%为2级(n=12)或3级(n=1)。
临床怎么用
- 作者认为,鉴于放射学椎体骨折继续新发或进展且与骨密度改善无关,日常临床实践中关注小梁骨丢失很重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In our prospective cohort with standardized bi-annual measurements of bone mineral density (BMD) and spinal radiographs, we evaluated the long-term course of BMD and the development of radiographic vertebral fractures (VFs) during 8 years of TNFi treatment in patients with radiographic axial spondyloarthritis (r-axSpA). METHODS: Consecutive axSpA patients from the GLAS cohort receiving TNFi for ≥8 years were included. Patients who received anti-osteoporotic treatment were excluded. Lumbar spine (LS) BMD was assessed at baseline, 1 year and bi-annually using DEXA. Radiographic VFs were evaluated using the Genant classification. RESULTS: 126 axSpA patients were included; 75 % male, mean age 42 ± 11 years, ASDAS 3.8 ± 0.8, median LS BMD Z-score -0.5 (IQR -1.4-0.7) and 20 % had radiographic VFs at baseline. Disease activity improved rapidly and sustained. LS BMD Z-score improved significantly up to 4 years compared to the previous time point and sustained thereafter. Median percentage of improvement compared to baseline was 8.9 % (2.8-15.8) and 7.2 % (2.2-14.7) after 4 and 8 years, respectively. Of 90 patients with baseline and 8-year radiographs, 14 (16 %) developed new VFs and 5 (6 %) showed an increase in severity of existing VFs. Of all 44 VFs present at 8 years, 30 % were grade 2 (n = 12) or grade 3 (n = 1). CONCLUSION: In r-axSpA patients treated with TNFi for 8 years, LS BMD Z-score increased significantly, especially during the first 4 year of treatment. Radiographic VFs continued to develop or progressed, irrespective of improvement in BMD. Therefore, clinical attention for trabecular bone loss is important in daily clinical practice.
引用
- Siderius M, Wink F, Kieskamp S, et al. Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis. Semin Arthritis Rheum. 2024. PMID: 39018730. doi:10.1016/j.semarthrit.2024.152523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。